Standardisation of Biomarker Validation for Implementation in Clinical Trials: Oncology & NASH as Case Studies

Time: 2:25 pm
day: Day Two Track A PM


  • General guiding principles for biomarker development
  • Best practices for the development and fit-for-purpose validation of biomarkers across a range of therapeutic areas, including NASH and oncology
  • Addressing the challenges in developing and implementing biomarker use in clinical trials and clinical practice
  • How are regulatory agencies addressing the need for validated biomarkers?